Literature DB >> 12244175

Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways.

Akio Masuda1, Yasunobu Yoshikai, Keiko Aiba, Tetsuya Matsuguchi.   

Abstract

Mast cells secrete multiple cytokines and play an important role in allergic inflammation. Although it is widely accepted that bacteria infection occasionally worsens allergic airway inflammation, the mechanism has not been defined. In this study, we show that LPS induced Th2-associated cytokine production such as IL-5, IL-10, and IL-13 from mast cells and also synergistically enhanced production of these cytokines induced by IgE cross-linking. LPS-mediated Th2-type cytokine production was abolished in mouse bone marrow-derived mast cells derived from C3H/HeJ mice, suggesting that Toll-like receptor 4 is essential for the cytokine production. Furthermore, we found that mitogen-activated protein kinases including extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinase, and p38 kinase were activated by LPS stimulation in bone marrow-derived mast cells. Inhibition of extracellular signal-regulated kinase activation has little effect on LPS-mediated cytokine production. In contrast, inhibition of c-Jun N-terminal kinase activation significantly suppressed both IL-10 and IL-13 expression at both mRNA and protein levels. Interestingly, although inhibition of p38 did not down-regulate the mRNA induction, it moderately decreased all three cytokine productions by LPS. These results indicate that LPS-mediated production of IL-5, IL-10, and IL-13 was distinctly regulated by mitogen-activated protein kinases. Our findings may indicate a clue to understanding the mechanisms of how bacteria infection worsens the clinical features of asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244175     DOI: 10.4049/jimmunol.169.7.3801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  IgE-dependent sensitization increases responsiveness to LPS but does not modify development of endotoxin tolerance in mast cells.

Authors:  Jaciel Medina-Tamayo; Alfredo Ibarra-Sánchez; Alejandro Padilla-Trejo; Claudia González-Espinosa
Journal:  Inflamm Res       Date:  2010-07-13       Impact factor: 4.575

Review 2.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 3.  Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation.

Authors:  Zhou Zhu; Sun Young Oh; You Sook Cho; Li Zhang; Yoon-Keun Kim; Tao Zheng
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 4.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells.

Authors:  Huihong Qiao; Marcus V Andrade; Felipe A Lisboa; Katrina Morgan; Michael A Beaven
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

6.  Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580.

Authors:  R D Koranteng; E J Swindle; B J Davis; R J Dearman; I Kimber; B F Flanagan; J W Coleman
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 7.  Toll-like receptors and immune response in allergic disease.

Authors:  Sophie C Gangloff; Moncef Guenounou
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

8.  TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells.

Authors:  Bianca Schaub; Abdelouahab Bellou; Fiona K Gibbons; German Velasco; Monica Campo; Hongzhen He; Yurong Liang; Matthew W Gillman; Diane Gold; Scott T Weiss; David L Perkins; Patricia W Finn
Journal:  J Interferon Cytokine Res       Date:  2004-09       Impact factor: 2.607

9.  Allograft inflammatory factor-1 regulates trinitrobenzene sulphonic acid-induced colitis.

Authors:  Taiki Morohashi; Kazuya Iwabuchi; Keiko Watano; Nyambayar Dashtsoodol; Tetsuya Mishima; Yukihito Nakai; Shigeki Shimada; Ryutaro Nishida; Satoshi Fujii; Kazunori Onoé
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

10.  Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.

Authors:  E Sloane; S Langer; B Jekich; J Mahoney; T Hughes; M Frank; W Seibert; G Huberty; B Coats; J Harrison; D Klinman; S Poole; S Maier; K Johnson; R Chavez; L R Watkins; L Leinwand; E Milligan
Journal:  Gene Ther       Date:  2009-07-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.